| 2024 | 2023 | 2022 | ||||
|---|---|---|---|---|---|---|
| Gross margin | 11,7 k € | -82.6% | 67,2 k € | -16.5% | 80,5 k € | |
| EBITDA | 10,8 k € | -83.9% | 67,0 k € | -16.2% | 79,9 k € | |
| Operating profit | -16,3 k € | -124.5% | 66,6 k € | -16.2% | 79,5 k € | |
| Profit/loss | -16,6 k € | -132.2% | 51,4 k € | -15.8% | 61,0 k € | |
| Equity | 98,3 k € | -14.4% | 114,9 k € | +80.9% | 63,5 k € | |
| Total assets | 106,8 k € | -13.3% | 123,3 k € | +68.9% | 73,0 k € | |
| Cash | 92,5 k € | -10.0% | 102,7 k € | +78.2% | 57,7 k € | |
| Debts | 8,5 k € | +1.7% | 8,4 k € | -11.5% | 9,5 k € | |
Source: Belgian Official Gazette
Private limited company loss-making in the latest fiscal year. Cash position declining (-10.0%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Dr. Michaël Metsers is a Private limited company incorporated in 2021. Its main activity is: Other human health activities. Its registered office is in Antwerpen.